The authors tested the immunosensor by detecting a new panel of autoantibodies against eight TAAs (GTF2B, MAPKAPK3, PIM1, PKN1, SRC, STK4, SULF1, and p53) in asymptomatic plasma samples, which were samples from premalignant individuals, CRC patients, and samples from breast and lung cancer patients. The gene discussed is TP53; the disease is colorectal carcinoma.